MedTrace Logo

DNA Diagnostic System for Statin Safety and Efficacy

NCT00767130 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2008-10-06

No results posted yet for this study

Summary

Lipitor®, Zocor®, and Crestor® are statin drugs commonly taken to lower cholesterol and prevent heart disease. Statins lower cholesterol by different amounts in different patients and sometimes statins cause muscle pain, cramps, or weakness. This study will examine genetic differences in the blood of patients taking statins to predict both how well the statins lower cholesterol, and whether muscle discomfort occurs. Finding such genetic connections is the key to developing genetic tests that might eventually help determine which statin is best for a patient. About 1000 people will be in the study.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Gualberto Ruano, MD, PhD · Genomas, Inc

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00767130 on ClinicalTrials.gov